| Temporal analysis of early immune responses in patients with acute hepatitis B virus infection C Dunn, D Peppa, P Khanna, G Nebbia, M Jones, N Brendish, RM Lascar, ... Gastroenterology 137 (4), 1289-1300, 2009 | 428 | 2009 |
| Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised … NJ Brendish, AK Malachira, L Armstrong, R Houghton, S Aitken, ... The Lancet Respiratory Medicine 5 (5), 401-411, 2017 | 303 | 2017 |
| Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions RO Payne, SE Silk, SC Elias, K Miura, A Diouf, F Galaway, H De Graaf, ... JCI insight 2 (21), 2017 | 146 | 2017 |
| Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination AM Minassian, SE Silk, JR Barrett, CM Nielsen, K Miura, A Diouf, C Loos, ... Med 2 (6), 701-719. e19, 2021 | 120 | 2021 |
| Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study NJ Brendish, S Poole, VV Naidu, CT Mansbridge, NJ Norton, H Wheeler, ... The Lancet Respiratory Medicine 8 (12), 1192-1200, 2020 | 117 | 2020 |
| Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus S Poole, NJ Brendish, AR Tanner, TW Clark The Lancet. Respiratory Medicine 8 (12), e92, 2020 | 109 | 2020 |
| SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study S Poole, NJ Brendish, TW Clark Journal of Infection 81 (6), 966-972, 2020 | 91 | 2020 |
| Inflammatory phenotyping predicts clinical outcome in COVID-19 H Burke, A Freeman, DC Cellura, BL Stuart, NJ Brendish, S Poole, ... Respiratory research 21, 1-9, 2020 | 82 | 2020 |
| Point-of-care testing for respiratory viruses in adults: the current landscape and future potential NJ Brendish, HF Schiff, TW Clark Journal of Infection 71 (5), 501-510, 2015 | 66 | 2015 |
| Influenza vaccination: protecting the most vulnerable AR Tanner, RB Dorey, NJ Brendish, TW Clark European Respiratory Review 30 (159), 2021 | 57 | 2021 |
| Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: a comparison of patients with and without SARS-CoV-2 infection NJ Brendish, S Poole, VV Naidu, CT Mansbridge, N Norton, F Borca, ... Journal of Infection 81 (6), 937-943, 2020 | 52 | 2020 |
| Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial NJ Brendish, AK Malachira, KR Beard, S Ewings, TW Clark European Respiratory Journal 52 (2), 2018 | 49 | 2018 |
| Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19 TW Clark, NJ Brendish, S Poole, VV Naidu, C Mansbridge, N Norton, ... Journal of Infection 81 (4), 607-613, 2020 | 40 | 2020 |
| Antiviral treatment of severe non-influenza respiratory virus infection NJ Brendish, TW Clark Current Opinion in Infectious Diseases 30 (6), 573-578, 2017 | 36 | 2017 |
| Safety and immunogenicity of ChAd63/MVA Pfs25-IMX313 in a phase I first-in-human trial H De Graaf, RO Payne, I Taylor, K Miura, CA Long, SC Elias, M Zaric, ... Frontiers in immunology 12, 694759, 2021 | 35 | 2021 |
| Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic … NJ Brendish, AK Malachira, TW Clark BMC Infectious Diseases 17, 1-8, 2017 | 31 | 2017 |
| Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19 TJM Wallis, E Heiden, J Horno, B Welham, H Burke, A Freeman, L Dexter, ... Respiratory research 22 (1), 157, 2021 | 30 | 2021 |
| Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised … TW Clark, KR Beard, NJ Brendish, AK Malachira, S Mills, C Chan, S Poole, ... The Lancet Respiratory Medicine 9 (4), 419-429, 2021 | 29 | 2021 |
| Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised … NJ Brendish, AK Malachira, L Armstrong, R Houghton, S Aitken, ... | 28 | |
| Treatment of influenza with neuraminidase inhibitors KR Beard, NJ Brendish, TW Clark Current Opinion in Infectious Diseases 31 (6), 514-519, 2018 | 27 | 2018 |
